13 September 2019 - - Swiss pharmaceutical group Vifor Pharma has hired Dr Klaus Henning Jensen as chief medical officer and Member of the executive committee in January 2020, the company said.
Dario Eklund, chief commercial officer and ...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
13 September 2019 - - German protein drug conjugates developer Tubulis and Glycotope, a clinical-stage immuno-oncology company, have signed a research and feasibility agreement, providing Glycotope access to Tubulis' proprietary antibody drug co...
13 September 2019 - - US-based third-party logistic services, patient access support and specialty pharmacy solutions provider McKesson and UK-based TrakCel, the software developer for cell and gene therapy supply chain tracking a...
13 September 2019 - - Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) has launched Fosaprepitant for Injection, the therapeutic generic equivalent of EMEND (fosaprepitant) for injection, appro...
13 September 2019 - - US-based Atomwise Inc., a specialist in artificial intelligence for drug discovery, and Atropos Therapeutics, Inc., a senescence platform discovery company, will launch a joint venture company to discover and advance a pipeline ...
13 September 2019 - Healthcare devices manufacturer Immunovia AB (STO:IMMNOV) announced on Thursday that the Beth Israel Deaconess Medical Centre (BIDMC) in Boston, Massachusetts will participate in the validation of IMMray PanCan-d as a part of the ...
13 September 2019 - Switzerland-based Roche's lung cancer drug Tecentriq (atezolizumab) has improved overall survival rate in a phase III IMpower110 study, it was reported yesterday.The trial is assessing the product as a first-line (initial) mo...